AU2224688A - New steroids containing a spiro ring 3,4 or 6 links in position 17, the process and intermediates for their preparation, their use as medicaments and the pharmaceutical compositions containing them - Google Patents

New steroids containing a spiro ring 3,4 or 6 links in position 17, the process and intermediates for their preparation, their use as medicaments and the pharmaceutical compositions containing them

Info

Publication number
AU2224688A
AU2224688A AU22246/88A AU2224688A AU2224688A AU 2224688 A AU2224688 A AU 2224688A AU 22246/88 A AU22246/88 A AU 22246/88A AU 2224688 A AU2224688 A AU 2224688A AU 2224688 A AU2224688 A AU 2224688A
Authority
AU
Australia
Prior art keywords
medicaments
intermediates
links
preparation
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU22246/88A
Other versions
AU620341B2 (en
Inventor
Martine Moguilewsky
Lucien Nedelec
Andre Clauss Ner
Daniel Philibert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of AU2224688A publication Critical patent/AU2224688A/en
Application granted granted Critical
Publication of AU620341B2 publication Critical patent/AU620341B2/en
Assigned to HOECHST MARION ROUSSEL reassignment HOECHST MARION ROUSSEL Alteration of Name(s) in Register under S187 Assignors: ROUSSEL-UCLAF
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU22246/88A 1987-09-11 1988-09-16 New steroids containing a spiro ring 3,4 or 6 links in position 17, the process and intermediates for their preparation, their use as medicaments and the pharmaceutical compositions containing them Ceased AU620341B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9610787A 1987-09-11 1987-09-11
US096107 1987-09-11

Publications (2)

Publication Number Publication Date
AU2224688A true AU2224688A (en) 1989-03-16
AU620341B2 AU620341B2 (en) 1992-02-20

Family

ID=22255374

Family Applications (2)

Application Number Title Priority Date Filing Date
AU22018/88A Abandoned AU2201888A (en) 1987-09-11 1988-09-09 Pharmaceutical combination
AU22246/88A Ceased AU620341B2 (en) 1987-09-11 1988-09-16 New steroids containing a spiro ring 3,4 or 6 links in position 17, the process and intermediates for their preparation, their use as medicaments and the pharmaceutical compositions containing them

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AU22018/88A Abandoned AU2201888A (en) 1987-09-11 1988-09-09 Pharmaceutical combination

Country Status (7)

Country Link
EP (1) EP0306846A3 (en)
JP (1) JPH01100118A (en)
KR (1) KR890004700A (en)
AU (2) AU2201888A (en)
DK (1) DK500388A (en)
IL (1) IL87721A0 (en)
ZA (1) ZA886716B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0784381B2 (en) * 1989-05-11 1995-09-13 田辺製薬株式会社 Thromboxane A ▲ 2 ▼ Antagonist
JPH0372419A (en) * 1989-05-16 1991-03-27 Tanabe Seiyaku Co Ltd Reversal agent against thromboxane a2
DE4001622A1 (en) * 1990-01-20 1991-07-25 Thomae Gmbh Dr K ORAL DRUGS OF PIMOBENDAN
AU5772396A (en) * 1995-05-19 1996-11-29 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
DE102004011512B4 (en) 2004-03-08 2022-01-13 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing pimobendan
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
ES2436716T3 (en) 2008-11-25 2014-01-03 Boehringer Ingelheim Vetmedica Gmbh Pimobendan for use in the treatment of hypertrophic cardiomyopathy in cats
EP3167876B1 (en) 2012-03-15 2021-09-08 Boehringer Ingelheim Vetmedica GmbH Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
CN113181110A (en) 2013-07-19 2021-07-30 勃林格殷格翰动物保健有限公司 Liquid aqueous pharmaceutical composition containing preserved etherified cyclodextrin derivatives
BR112016011111B1 (en) 2013-12-04 2022-11-16 Boehringer Ingelheim Vetmedica Gmbh IMPROVED PHARMACEUTICAL COMPOSITIONS OF PIMOBENDAN
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
KR102199332B1 (en) * 2019-01-30 2021-01-06 한국생산기술연구원 Smart mixing device for confectionery and bakery using multiple mixing bowls with different colors

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4568676A (en) * 1983-11-25 1986-02-04 Thomas Jefferson University Method of inhibiting aggregation using thromboxane synthetase inhibitor in combination with a cyclic AMP phosphodiesterase inhibitor
FR2596395B1 (en) * 1986-03-26 1989-05-26 Roussel Uclaf NOVEL STEROIDS COMPRISING A SPIRANIC CYCLE IN POSITION 17, THEIR PREPARATION METHOD, THEIR APPLICATION AS MEDICAMENTS AND THE COMPOSITIONS CONTAINING THEM
DE3631294A1 (en) * 1986-09-13 1988-03-24 Thomae Gmbh Dr K NEW SYNERGISTIC COMBINATION CONSISTING OF A PHOSPHODIESTERASE INHIBITOR AND A THROMBOXAN-A (ARROW DOWN) 2 (ARROW DOWN) ANTAGONISTS AND THEIR USE OR THEIR USE. MANUFACTURING

Also Published As

Publication number Publication date
AU620341B2 (en) 1992-02-20
EP0306846A3 (en) 1990-05-02
DK500388A (en) 1989-03-12
IL87721A0 (en) 1989-02-28
ZA886716B (en) 1990-05-30
JPH01100118A (en) 1989-04-18
EP0306846A2 (en) 1989-03-15
KR890004700A (en) 1989-05-09
AU2201888A (en) 1989-04-27
DK500388D0 (en) 1988-09-09

Similar Documents

Publication Publication Date Title
ZA872130B (en) Steroids including a spiro ring in position 17,the process and the intermediates for their preparation,their use as medicaments,and the pharmaceutical compositions containing them
AU5988986A (en) Phenylethanolaminoeteralines, a process for their preparation and pharmaceutical compositions containing them
AU6824190A (en) Intermediates for substituted 9-amino-tetrahydro-acridines, a process for their preparation and their use as medicaments
ZA899434B (en) 9-a2a-3-(oxa-thia)-biocyclo 3,2,1 nonane derivatives,process intermediates for their preparation and pharmaceutical compositions containing them
AU7171787A (en) 1-hydroxy-2-pyridones, a process for their preparation, and medicaments which contain them, and intermediates formed in the preparation of the 1-hydroxy-2-pyridones
AU623766B2 (en) N-heteroaryl-4-quinolinamines, a process for their preparation and their use as medicaments
AU8245087A (en) New pyrrolobenzimidazoles, processes for the preparation thereof and pharmaceutical compositions containing them
AU2224688A (en) New steroids containing a spiro ring 3,4 or 6 links in position 17, the process and intermediates for their preparation, their use as medicaments and the pharmaceutical compositions containing them
AU2043488A (en) 1-phenyl-3-(1-piperazinyl)-1h-indazoles, a process and intermediates for their preparation, and the use thereof as medicaments
IL86027A (en) 2-acylpyrrolidine derivatives,a process for the preparation thereof,compositions containing them,and their use
AU4246489A (en) New benzoxazolinone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
EP0434571A3 (en) New steroid derivatives with a substituted ethyl group on the position 10, process for their production, their use as medicines and pharmaceutical compositions containing them
AU5493190A (en) Thieno-triazolo-diazepine derivatives, a preparation process of the same and therapeutic compositions containing them
AU601787B2 (en) Substituted aminomethyl-5,6,7,8-tetrahydronaphthyloxy-acetic acids, new intermediate products, processes for their preparation and their use as medicaments
AU8306987A (en) Novel carbamoyloxylabdanes, intermediates and a process for the preparation thereof and their use as medicaments
AU7199487A (en) Benzothiazinone derivatives, processes for their preparation medicaments containing them and their use
AU8182187A (en) Medicaments based on derivatives of 3,4-diphenylpiperidine the use of the derivatives as medicaments, and novel 3,4- diphenylpiperidine derivatives and a process for the preparation thereof
ZA878659B (en) 12-halogenated forskolin derivatives,intermediates and a process for the preparation thereof and their use as medicaments
AU6101990A (en) Pyrido (3,4-b)(1,4)benzoxazepines, a process for their preparation and their use as medicaments
AU609980B2 (en) Hydrazinocarbonyloxylabdanes, a process for their preparation and their use as medicaments
AU5870190A (en) 6- and 7-deoxyforskolin and derivatives thereof, intermediates and a process for their preparation and their use as medicaments
AU2464988A (en) New acyllabdane derivatives, a process for their preparation,and their use as medicaments
ZA88409B (en) 3-methylenespiro/benzofuranpiperidines/,intermediates and a process for the preparation thereof,and their use as medicaments
AU6840790A (en) Thienobenzoxepin- and naphthothiophene-derivatives, a process and intermediates for their preparation and their use as medicaments
AU2193588A (en) N-(substituted alkylidene)fused-bicycloalkylidene and heteroalkylidene quinolinamines, a process for their preparation and their use as medicaments

Legal Events

Date Code Title Description
MK14 Patent ceased section 143(a) (annual fees not paid) or expired